REG - Datalex PLC Datalex PLC - DLE - Results of Firm Placing and Placing

DatalexAnnouncement

28/08/2024 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240828:nRSb0436Ca&default-theme=true

RNS Number : 0436C  Datalex PLC  28 August 2024

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE
OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH
AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION
OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICE SECTION OF
THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF
SECURITIES IN ANY JURISDICTION.

 

This announcement is released by Datalex plc and contains inside information
for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014
("EU MAR") and is disclosed in accordance with the Company's obligations under
Article 17 of EU MAR.

28 August 2024

 

DATALEX PLC ("Datalex" or the "Company")

 

Results of Firm Placing and Placing

Datalex is pleased to announce that, following the announcement made earlier
today regarding the details of a proposed Firm Placing and Placing and Open
Offer (the "Capital Raise"), in aggregate 55,469,070 New Ordinary Shares are
to be issued pursuant to the Capital Raise, at an issue price of €0.45 per
New Ordinary Share (the "Issue Price"), raising gross proceeds of
approximately €25.0 million (approximately €24.3 million net of fees and
expenses). Of these, 37,777,777 New Ordinary Shares have been placed pursuant
to the Firm Placing and 17,691,293 New Ordinary Shares have been placed,
subject to clawback under the Open Offer, pursuant to the Placing.

The New Ordinary Shares to be issued represent 41.8% of the Existing Ordinary
Shares and will represent 29.5% of the enlarged issued share capital of the
Company (immediately following completion of the Capital Raise).

The Firm Placing

 

A total of 37,777,777 New Ordinary Shares have been successfully placed
pursuant to the Firm Placing at the Issue Price, raising approximately €17.0
million (prior to deduction of fees and expenses).

The Firm Placed Shares are not subject to clawback and do not form part of the
Placing and Open Offer. The Firm Placing is subject to the same conditions and
termination rights which apply to the Placing and Open Offer.

The Placing and Open Offer

A further approximately €8.0 million (prior to deduction of fees and
expenses) is intended to be raised by way of the Placing and Open Offer. The
Open Offer, participation in which will be available to Qualifying
Shareholders, will commence following publication of a Circular by the
Company. Goodbody has conditionally placed all of the Placed Shares at the
Issue Price to IIU Nominees for in aggregate approximately €8.0 million. The
commitments of IIU Nominees under the Placing are subject to clawback in
respect of valid applications for Open Offer Shares by Qualifying
Shareholders.

 

Subject to Independent Shareholders' approval and the Placing and Open Offer
not being terminated, any Open Offer Shares which are not applied for in
respect of the Open Offer will be issued to IIU Nominees, with the net
proceeds retained for the benefit of the Company.

 

Completion of the Capital Raise will be conditional, amongst other things, on
approval by Shareholders (including that of Independent Shareholders) at an
Extraordinary General Meeting of the Company which is expected to be held on
26 September 2024.

Admission is expected to become effective, and dealings to commence in the New
Ordinary Shares on Euronext Growth, at 8.00 a.m. (Dublin time) on 27 September
2024.

Capitalised terms used in this announcement (this "Announcement"), which have
not been defined have the meanings given to them in the announcement made by
the Company earlier today announcing the Capital Raise, unless the context
provides otherwise.

 

 

For further information, please
contact:

 Datalex plc                                              Tel: +353 (1) 806 3500

 Jonathan Rockett   Chief Executive Officer

 Steven Moloney     Chief Financial Officer

 Neil McLoughlin    Chief Commercial & Legal Officer

 

 Goodbody - Euronext Growth Listing Sponsor, Corporate Broker, Financial  Tel: +353 (0) 1 667 0420
 Adviser, Bookrunner

 Cameron Duncan

 Peter Bennett

 William Hall

 Xiao Wang

 

 

Important Notices

This Announcement has been issued by, and is the sole responsibility of, the
Company. No representation or warranty, express or implied, is or will be made
as to, or in relation to, and no responsibility or liability is or will be
accepted by Goodbody or by any of its affiliates or agents as to, or in
relation to, the accuracy or completeness of this Announcement or any other
written or oral information made available to or publicly available to any
interested party or its advisers in connection with the Firm Placing, Placing
and Admission, and any liability therefor is expressly disclaimed.

Goodbody Stockbrokers UC ("Goodbody"), which is authorised and regulated in
Ireland by the CBI, is acting for the Company as Bookrunner in connection with
the Capital Raise and no-one else in connection with the Capital Raise and is
not, and will not be, responsible to anyone other than the Company for
providing the protections afforded to its clients nor for providing advice in
relation to the Firm Placing and Placing and/or any other matter referred to
in this Announcement.

 

Apart from the responsibilities and liabilities, if any, which may be imposed
on the Bookrunner by the Financial Services and Markets Act 2000 of the United
Kingdom or by the regulatory regime established under it, neither Goodbody nor
any of its affiliates owes or accepts any duty, liability or responsibility
whatsoever to any person who is not a client for the contents of the
information contained in this Announcement or for any other statement made or
purported to be made by or on behalf of the Bookrunner or its affiliates in
connection with the Company, the Firm Placing or Placing. Goodbody and each of
its affiliates accordingly disclaim all and any liability, whether arising in
tort, contract or otherwise (save as referred to above) in respect of any
statements or other information contained in this Announcement and no
representation or warranty, express or implied, is made by the Goodbody or any
of its affiliates as to the accuracy, completeness or sufficiency of the
information contained in this Announcement. Neither Goodbody nor any of its
affiliates, directors, officers, employees, agents or advisors have authorised
the contents of, or any part of, this Announcement.

In connection with the Firm Placing and Placing, Goodbody and any of its
affiliates may take up a portion of the shares in the Firm Placing or Placing
as a principal position and in that capacity may retain, purchase, sell, offer
to sell for its own account such shares and other securities of the Company or
related investments in connection with the Firm Placing, Placing or otherwise.
Accordingly, references to Firm Placing Shares and Placed Shares being
offered, acquired, placed or otherwise dealt in should be read as including
any issue or offer to, or acquisition, placing or dealing by Goodbody and any
of its affiliates acting in such capacity. In addition, Goodbody and any of
its affiliates may enter into financing arrangements (including swaps,
warrants or contracts for differences) with investors in connection with which
Goodbody and any of its affiliates may from time to time acquire, hold or
dispose of shares. Goodbody does not intend to disclose the extent of any such
investment or transactions otherwise than in accordance with any legal or
regulatory obligations to do so.

Goodbody and its affiliates may have engaged in transactions with, and
provided various commercial banking, investment banking, financial advisory
transactions and services in the ordinary course of its business with the
Company and/or its affiliates for which they would have received customary
fees and commissions. Goodbody and its affiliates may provide such services to
the Company and/or its affiliates in the future.

Members of the public are not eligible to take part in the Firm Placing or
Placing. All offers of the Firm Placing Shares and Placed Shares will be made
pursuant to an exemption under Regulation (EU) 2017/1129 (the "Prospectus
Regulation") from the requirement to produce a prospectus for offers of the
Firm Placing Shares and Placed Shares. This Announcement is directed only at
and may only be communicated to: (A) persons in a Member State of the European
Economic Area who are qualified investors ("Qualified Investors") within the
meaning of Article 2(e) of the Prospectus Regulation; or (B) in the United
Kingdom, Qualified Investors who are also (A) persons having professional
experience in matters relating to investments who fall within the definition
of "investment professional" in Article 19(5) of the Financial Services and
Markets Act 2000 (Financial Promotion) Order 2005 of the United Kingdom, as
amended (the "Order"), (B) persons who fall within Article 49(2)(a) to (d)
("High Net Worth Companies, Unincorporated Associations, etc") of the Order;
or (C) persons to whom it may otherwise be lawfully communicated including the
Company Placing Participants (all such persons referred to in (A), (B) and (C)
above together being referred to as "Relevant Persons").

This Announcement is not for publication or distribution, directly or
indirectly, in or into the United States of America. This Announcement is not
an offer of securities for sale into the United States. The offer and sale of
the securities referred to herein have not been and will not be registered
under the U.S. Securities Act of 1933, as amended, and such securities may not
be offered or sold in the United States, except pursuant to an applicable
exemption from registration.  No public offering of securities is being made
in the United States.

This Announcement must not be acted on or relied on by persons who are not
Relevant Persons. Persons distributing this Announcement must satisfy
themselves that it is lawful to do so. Any investment or investment activity
to which this Announcement relates is available only to Relevant Persons and
will be engaged in only with Relevant Persons. This Announcement is for
information purposes only and shall not constitute an offer to sell or issue
or the solicitation of an offer to buy, subscribe for or otherwise acquire
securities in any jurisdiction in which any such offer or solicitation would
be unlawful. Any failure to comply with this restriction may constitute a
violation of the securities laws of such jurisdictions. Persons needing advice
should consult an independent financial adviser.

This Announcement and the information contained herein is restricted and is
not for release, publication or distribution, directly or indirectly, in whole
or in part, in, into or from Australia, Canada, Japan, the Republic of South
Africa or any other state or jurisdiction in which the same would be
restricted, unlawful or unauthorised (each a "Restricted Territory"). In
addition, the offering of the Firm Placing Shares or Placed Shares in certain
jurisdictions may be restricted by law. This Announcement is for information
purposes only and does not constitute an offer to buy, sell, issue, acquire or
subscribe for, or the solicitation of an offer to buy, sell, issue, acquire or
subscribe for shares in the capital of the Company in any Restricted Territory
or to any person to whom it is unlawful to make such offer or solicitation. No
action has been taken by the Company or the Bookrunner that would permit an
offering of such shares or possession or distribution of this Announcement or
any other offering or publicity material relating to such shares in any
jurisdiction where action for that purpose is required. Persons into whose
possession this Announcement comes are required by the Company and the
Bookrunner to inform themselves about, and to observe, such restrictions. Any
failure to comply with these restrictions may constitute a violation of the
securities laws of such jurisdictions.

The information in this Announcement may not be forwarded or distributed to
any other person and may not be reproduced in any manner whatsoever. Any
forwarding, distribution, reproduction, or disclosure of this information in
whole or in part is unauthorised. Failure to comply with this directive may
result in a violation of the Securities Act or the applicable laws of other
jurisdictions.

This Announcement does not identify or suggest, or purport to identify or
suggest, the risks (direct or indirect) that may be associated with an
investment in the Firm Placing Shares and Placed Shares. Any investment
decision to buy Firm Placing Shares or Placed Shares in the Placing must be
made solely on the basis of publicly available information, which has not been
independently verified by the Bookrunner. The contents of this Announcement
are not to be construed as legal, financial or tax advice. Persons needing
advice should consult an independent financial adviser.

Solely for the purposes of the product governance requirements contained
within: (a) EU Directive 2014/65/EU on markets in financial instruments, as
amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive
(EU) 2017/593 supplementing MiFID II; and (c) local implementing measures
(together, the "MiFID II Product Governance Requirements"), and disclaiming
all and any liability, whether arising in tort, contract or otherwise, which
any 'manufacturer' (for the purposes of the MiFID II Product Governance
Requirements) may otherwise have with respect thereto, the Firm Placing Shares
and Placed Shares have been subject to a product approval process, which has
determined that such Firm Placing and Placed Shares are: (i) compatible with
an end target market of retail investors and investors who meet the criteria
of professional clients and eligible counterparties, each as defined in MiFID
II; and (ii) eligible for distribution through all distribution channels as
are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding
the Target Market Assessment, distributors should note that: the price of the
Firm Placing Shares and Placed Shares may decline and investors could lose all
or part of their investment; the Firm Placing Shares and Placed Shares offer
no guaranteed income and no capital protection; and an investment in the Firm
Placing Shares or Placed Shares is compatible only with investors who do not
need a guaranteed income or capital protection, who (either alone or in
conjunction with an appropriate financial or other adviser) are capable of
evaluating the merits and risks of such an investment and who have sufficient
resources to be able to bear any losses that may result therefrom.

The Target Market Assessment is without prejudice to the requirements of any
contractual, legal or regulatory selling restrictions in relation to the
Placing. Furthermore, it is noted that, notwithstanding the Target Market
Assessment, The Bookrunner will only procure investors who meet the criteria
of professional clients and eligible counterparties or who are Company Placing
Participants. For the avoidance of doubt, the Target Market Assessment does
not constitute: (a) an assessment of suitability or appropriateness for the
purposes of MiFID II; or (b) a recommendation to any investor or group of
investors to invest in, or purchase or take any other action whatsoever with
respect to the Firm Placing Shares and Placed Shares. Each distributor is
responsible for undertaking its own target market assessment in respect of the
Firm Placing Shares and Placed Shares and determining appropriate distribution
channels.

Certain statements contained in this Announcement are or may constitute
"forward-looking statements". By their nature, forward-looking statements
involve risk and uncertainty because they relate to events and depend upon
future circumstances that may or may not occur, many of which are beyond the
control of the Company and all of which are based on its current beliefs and
expectations about future events. Such forward-looking statements involve
known and unknown risks, uncertainties and other factors, which may cause the
actual results, performance or achievements of the Group, or industry results,
to be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Such
forward- looking statements are based on numerous assumptions regarding the
present and future business strategies of the Group and the environment in
which the Group will operate in the future. These forward-looking statements
speak only as at the date of this Announcement.

Forward-looking statements are typically identified by the use of
forward-looking terminology such as "believes", "expects", "may", "will",
"would", "should", "intends", "estimates", "plans", "assumes" or "anticipates"
or the negative of such words or other variations on them or comparable
terminology, or by discussions of strategy which involve risks and
uncertainties. Such risks, uncertainties and other factors include, among
others: the macroeconomic and other impacts of COVID-19, general economic and
business conditions, changes in technology, government policy and ability to
attract and retain personnel. Except as required by applicable law, the
Listing Rules and other regulations, Euronext Dublin or by any appropriate
regulatory body, Datalex plc expressly disclaims any obligation or undertaking
to release publicly any updates or revisions to any forward-looking statements
contained herein to reflect any change in the Group's expectations with regard
thereto or any change in events, conditions or circumstances on which any such
statement is based.

Past performance may not be a reliable guide to future performance.
Investments may fall as well as rise in value. Income may fluctuate in
accordance with market conditions and taxation arrangements. Changes in
exchange rates may have an adverse effect on the value, price or income of the
Ordinary Shares, including the New Ordinary Shares the subject of the Open
Offer.

Euronext Growth is a market designed primarily for emerging or smaller
companies to which a higher investment risk tends to be attached than to
larger or more established companies. Euronext Growth securities are not
admitted to the Official List of Euronext Dublin. The Euronext Growth Rules
are less demanding than those of the Official List of Euronext Dublin. A
prospective investor should be aware of the risks of investing in such
companies and should make the decision to invest only after careful
consideration and, if appropriate, consultation with an independent financial
advisor.

Certain numbers in this Announcement have been rounded up or down. There may
therefore be discrepancies between the actual totals of the individual amounts
in this Announcement and the underlying data.

The New Ordinary Shares to be issued pursuant to the Firm Placing and Placing
will not be admitted to trading on any stock exchange other than the Euronext
Growth Market of Euronext Dublin. Persons (including individuals, funds or
otherwise) by whom or on whose behalf a commitment to acquire Firm Placing
Shares or Placed Shares has been given ("Placees") will be deemed to have read
and understood this Announcement in its entirety (including the Appendix) and
to be making such offer on the Terms and Conditions in it, and to be providing
the representations, warranties, indemnities, acknowledgements, and
undertakings contained in the Appendix.

In particular, each such Placee will be asked to represent, warrant and
acknowledge that: (i) it is a Relevant Person (as defined in the Appendix) and
undertakes that it will acquire, hold, manage or dispose of any Firm Placing
Shares and Placed Shares that are allocated to it for the purposes of its
business and it is acquiring such shares for its own account; (ii) it and any
account with respect to which it exercises sole investment discretion, is
either (a) outside the United States, or (b) a QIB; and (iii) if it is a
financial intermediary, as that term is used in Article 2(d) of the Prospectus
Regulation, that it understands the resale and transfer restrictions set out
in the Appendix  and that any Firm Placing Shares or Placed Shares acquired
by it in the Firm Placing or Placing will not be acquired on a
non-discretionary basis on behalf of, nor will they be acquired with a view to
their offer or resale to, persons in circumstances which may give rise to an
offer of securities to the public other than an offer or resale in a member
state of the EEA to Qualified Investors or in the United Kingdom to Relevant
Persons, or in circumstances in which the prior consent of the Bookrunner has
been given to each such proposed offer or resale.

Persons (including, without limitation, nominees and trustees) who have a
contractual or other legal obligation to forward a copy of the Appendix or
this Announcement should seek appropriate advice before taking any action.

No prospectus or offering document will be made available in connection with
the matters contained in this Announcement and no such prospectus or offering
document is required (in accordance with the Prospectus Regulation) to be
published. This Announcement has not been approved by the Central Bank of
Ireland, Euronext Dublin, or any other competent regulatory authority.

The most recent Annual Report, trading update and other information relating
to the Company are available on the Datalex website at www.datalex.com
(//www.datalex.com) . Neither the content of the Company's website nor any
website accessible by hyperlinks on the Company's website is incorporated in,
or forms part of, this Announcement.

This Announcement does not constitute a recommendation concerning the Firm
Placing or Placing.

By choosing to participate in the Firm Placing and Placing and by making an
oral and legally binding offer to acquire Firm Placing and Placed Shares,
investors will be deemed to have read and understood this Announcement in its
entirety (including the Appendix) and to be making such offer on the terms and
subject to the conditions in it, and to be providing the representations,
warranties, indemnities, acknowledgements and undertakings contained in the
Appendix.

This Announcement should be read in its entirety. In particular, you should
read and understand the information provided in the "Important Notices"
section of this Announcement.

References in this Announcement to IIU's pro rata entitlement to participate
in the Open Offer exclude any entitlement in respect of certain Ordinary
Shares in the Company held by IIU Nominees in the form of American Depositary
Receipts in respect of which, for U.S. securities law reasons, IIU Nominees
shall not qualify to participate in the Open Offer.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEBUGDIBGDDGSI